Inventor · Spring House, PA, US

John Wheeler

26Patents
6h-index
76Co-inventors
68Inventor score

Filing activity: Aug 25, 2009 → Mar 30, 2023

Most-cited inventions

PatentTitleAreaCited byStatus
US9102737B2 Human anti-CD27 antibodies, methods and uses Chemistry; Metallurgy 26 Active
US9090694B2 ST2L antibody antagonists Chemistry; Metallurgy 18 Active
US9212227B2 ST2L antibody antagonists for the treatment of ST2L-mediated inflammatory pulmonary conditions Chemistry; Metallurgy 12 Active
US9850310B2 CD123 binding agents and uses thereof Chemistry; Metallurgy 12 Active
US8394378B2 Antibodies binding human collagen II Chemistry; Metallurgy 10 Active
US9683046B2 Nucleic acid molecules encoding anti-CD27 antibodies Chemistry; Metallurgy 7 Active
US8785605B2 Humanized IL-25 antibodies Chemistry; Metallurgy 4 Active
US9951137B2 ST2L antagonists and methods of use Chemistry; Metallurgy 2 Active
US10301392B2 Methods of inhibiting T-cell mediated B-cell antibody production using anti-CD27 antibodies Chemistry; Metallurgy 2 Active
US10450377B2 ST2L antagonists and methods of use Chemistry; Metallurgy 1 Active
US10829549B2 Anti-CCL17 antibodies Emerging Cross-Sectional Technologies 1 Active
US9944697B2 Anti-CCL17 antibodies Emerging Cross-Sectional Technologies 1 Active
US10633435B2 Anti-PHF-tau antibodies and uses thereof Physics 0 Active
US11414484B2 Anti-CCL17 antibodies Emerging Cross-Sectional Technologies 0 Active
US9062305B2 Generation of human de novo pIX phage display libraries Chemistry; Metallurgy 0 Active
US8906649B2 Antibodies binding human collagen II Chemistry; Metallurgy 0 Active
US9808649B2 Immobilization system to support an in vivo medical device Human Necessities 0 Active
US12269888B2 Artificial cell death polypeptide for chimeric antigen receptor and uses thereof Chemistry; Metallurgy 0 Active
US10689453B2 Methods of inhibiting naive T-cell proliferation using anti-CD27 antibodies Chemistry; Metallurgy 0 Active
US12234280B2 Anti-PHF-tau antibodies and uses thereof Physics 0 Active
US11661459B2 Artificial cell death polypeptide for chimeric antigen receptor and uses thereof Chemistry; Metallurgy 0 Active
US10207856B2 Liquid release device Performing Operations; Transporting 0 Active
US11732050B2 Neutralizing human anti-CD27 antibodies Chemistry; Metallurgy 0 Active
US8822423B2 Affinity peptides toward infliximab Chemistry; Metallurgy 0 Active
US11883432B2 Chimeric antigen receptor system with adaptable receptor specificity Chemistry; Metallurgy 0 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.